Prevalence, genotype distribution and risk factors of cervical HPV infection in Yangqu, China: a population-based survey of 10086 women

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. doi:10.3322/caac.21262.
   PubMed Web of Science ®Google Scholar
• Gutierrez-Xicotencatl L, Salazar-Pina DA, Pedroza-Saavedra A, Chihu-Amparan L, Rodriguez-Ocampo AN, Maldonado-Gama M, Esquivel-Guadarrama FR. Humoral Immune response against human papillomavirus as source of biomarkers for the prediction and detection of cervical cancer. Viral Immunol. 2016;29:83–94. doi:10.1089/vim.2015.0087.
   PubMed Web of Science ®Google Scholar
• Senapati R, Nayak B, Kar SK, Dwibedi B. HPV genotypes co-infections associated with cervical carcinoma: special focus on phylogenetically related and non-vaccine targeted genotypes. PLoS One. 2017;12:e0187844. doi:10.1371/journal.pone.0187844.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang J, Fan J, Zhao W, Yang X, Wu L, Li D, Ding L, Wang W, Xu J, et al. Risk factors for cervical intraepithelial neoplasia and cervical cancer in Chinese women: large study in Jiexiu, Shanxi Province, China. J Cancer. 2017;8(6):924–32. doi:10.7150/jca.17416jcav08p0924.
   PubMed Web of Science ®Google Scholar
• Zhao W, Hao M, Wang Y, Feng N, Wang Z, Wang W, Wang J, Ding L. Association between folate status and cervical intraepithelial neoplasia. Eur J Clin Nutr. 2016;70(7):837–42. doi:10.1038/ejcn.2016.35ejcn201635.
   PubMed Web of Science ®Google Scholar
• de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Muñoz N, Bosch FX. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7:453–59. doi:10.1016/S1473-3099(07)70158-5.
   PubMed Web of Science ®Google Scholar
• Castellsague X, Menendez C, Loscertales MP, Kornegay JR, Dos Santos F, Gomez-Olive FX, Lloveras B, Abarca N, Vaz N, Barreto A, et al. Human papillomavirus genotypes in rural Mozambique. Lancet. 2001;358:1429–30. doi:10.1016/S0140-6736(01)06523-0.
   PubMed Web of Science ®Google Scholar
• Obiri-Yeboah D, Akakpo PK, Mutocheluh M, Adjei-Danso E, Allornuvor G, Amoako-Sakyi D, Adu-Sarkodie Y, Mayaud P. Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women. BMC Cancer. 2017;17:688. doi:10.1186/s12885-017-3682-x.
   PubMed Web of Science ®Google Scholar
• Munoz N, Franco EL, Herrero R, Andrus JK, de Quadros C, Goldie SJ, Bosch FX. Recommendations for cervical cancer prevention in Latin America and the Caribbean. Vaccine. 2008;26(Suppl 11):L96–L107. doi:10.1016/j.vaccine.2008.05.062.
   PubMedGoogle Scholar
• Zhao Y, Zhao F, Hu S, Chen W, Chen F, Cui J, Liu B, Zhang W, Zhang X, Pan Q, et al. Multi-center cross-sectional study on type-specific human papillomavirus infection among Chinese women. Zhonghua Liu Xing Bing Xue Za Zhi. 2015;36:1351–56.
   PubMedGoogle Scholar
• Guo F, Hirth JM, Berenson AB. Comparison of HPV prevalence between HPV-vaccinated and non-vaccinated young adult women (20–26 years). Hum Vaccin Immunother. 2015;11:2337–44. doi:10.1080/21645515.2015.1066948.
   PubMed Web of Science ®Google Scholar
• Oliveira CR, Rock RM, Shapiro ED, Xu X, Lundsberg L, Zhang LB, Gariepy A, Illuzzi JL, Sheth SS. Missed opportunities for HPV immunization among young adult women. Am J Obstet Gynecol. 2018;218(3):326.
   Web of Science ®Google Scholar
• Bahrami A, Hasanzadeh M, Shahidsales S, Farazestanian M, Hassanian SM, Moetamani Ahmadi M, Maftouh M, Gharib M, Yousefi Z, Kadkhodayan S, et al. Genetic susceptibility in cervical cancer: from bench to bedside. J Cell Physiol. 2018;233:1929–39. doi:10.1002/jcp.v233.3.
   PubMed Web of Science ®Google Scholar
• Schiffman M, Wentzensen N. Effective use of human papillomavirus testing for cervical cancer screening requires extended intervals to target persistent infections and precancerous lesions. Prev Med. 2017;105:378–80. doi:10.1016/j.ypmed.2017.09.010.
   PubMed Web of Science ®Google Scholar
• Wang X, Ji Y, Li J, Dong H, Zhu B, Zhou Y, Wang J, Zhou X, Wang Y, Peppelenbosch MP, et al. Prevalence of human papillomavirus infection in women in the autonomous region of Inner Mongolia: A population-based study of a Chinese ethnic minority. J Med Virol. 2018;90:148–56. doi:10.1002/jmv.v90.1.
   PubMed Web of Science ®Google Scholar
• Farsi NJ, Rousseau M-C, Schlecht N, Castonguay G, Allison P, Nguyen-Tan PF, Souliéres D, Coutlée F, Hier M, Madathil S, et al. Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol. Carcinogenesis. 2017;38:1188–95. doi:10.1093/carcin/bgx106.
   PubMed Web of Science ®Google Scholar
• Khoo SP, Bhoo-Pathy N, Yap SH, Anwar Shafii MK, Hairizan Nasir N, Belinson J, Subramaniam S, Goh PP, Zeng M, Tan HD, et al. Prevalence and sociodemographic correlates of cervicovaginal human papillomavirus (HPV) carriage in a cross-sectional, multiethnic, community-based female Asian population. Sex Transm Infect. 2018;94(4):277–83.
   Web of Science ®Google Scholar
• Ma S, Stern JE, Feng Q, Hughes JP, Hawes SE, Winer RL. Incidence and risk factors for human papillomavirus infections in young female online daters. J Med Virol. 2017;89:2029–36. doi:10.1002/jmv.v89.11.
   PubMed Web of Science ®Google Scholar
• Cao D, Zhang S, Zhang Q, Wei X, Zhao M, Ma Q, Li Y, Wang L, Pei M, Yang T, et al. Prevalence of high-risk human papillomavirus infection among women in Shaanxi province of China: A hospital-based investigation. J Med Virol. 2017;89:1281–86. doi:10.1002/jmv.24748.
   PubMed Web of Science ®Google Scholar
• Shi N, Lu Q, Zhang J, Li L, Zhang F, Dong Y, Zhang X, Zhang Z, Gao W. Analysis of risk factors for persistent infection of asymptomatic women with high-risk human papilloma virus. Hum Vaccin Immunother. 2017;13:1–7. doi:10.1080/21645515.2016.1239669.
   Web of Science ®Google Scholar
• Shakya S, Syversen U, Asvold BO, Bofin AM, Aune G, Nordbo SA, Vaidya KM, Karmacharya BM, Afset JE, Tingulstad S. Prevalence of human papillomavirus infection among women in rural Nepal. Acta Obstet Gynecol Scand. 2017;96:29–38. doi:10.1111/aogs.13036.
   PubMed Web of Science ®Google Scholar
• Baloch Z, Yasmeen N, Li Y, Ma K, Wu X, Yang SH, Xia X. Prevalence and risk factors for human papillomavirus infection among Chinese ethnic women in southern of Yunnan, China. Braz J Infect Dis. 2017;21:325–32. doi:10.1016/j.bjid.2017.01.009.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Cao D, Ma Q, Li N, Cui XQ, Yang XF. Natural outcome of genital tract high-risk human papillomavirus infection and associated factors among 760 women. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2015;37:534–40. doi:10.3881/j.issn.1000-503X.2015.05.008.
   PubMedGoogle Scholar
• Mollers M, Boot Hein J, Vriend Henrike J, King Audrey J, van den Broek Ingrid VF, van Bergen Jan EA, Brink Antoinette ATP, Wolffs Petra FG, Hoebe Christian JPA, Meijer Chris JLM, et al. Prevalence, incidence and persistence of genital HPV infections in a large cohort of sexually active young women in the Netherlands. Vaccine. 2013;31:394–401. doi:10.1016/j.vaccine.2012.10.087.
   PubMed Web of Science ®Google Scholar
• Louvanto K, Rintala MA, Syrjanen KJ, Grenman SE, Syrjanen SM. Genotype-specific persistence of genital human papillomavirus (HPV) infections in women followed for 6 years in the Finnish family HPV study. J Infect Dis. 2010;202:436–44. doi:10.1086/653015.
   PubMed Web of Science ®Google Scholar
• Ma Q, Hou M, Yang XF. Screening of the genital human papillomavirus infection among 8581 women in the first affiliated hospital of Xi’an Jiaotong University. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2014;36:277–82. doi:10.3881/j.issn.1000-503X.2014.03.009.
   PubMedGoogle Scholar
• Di Paola M, Sani C, Clemente AM, Iossa A, Perissi E, Castronovo G, Tanturli M, Rivero D, Cozzolino F, Cavalieri D, et al. Characterization of cervico-vaginal microbiota in women developing persistent high-risk human papillomavirus infection. Sci Rep. 2017;7:10200. doi:10.1038/s41598-017-09842-6.
   PubMed Web of Science ®Google Scholar
• Zhong TY, Zhou JC, Hu R, Fan XN, Xie XY, Liu ZX, Lin M, Chen Y-G, Hu X-M, Wang W-H, et al. Prevalence of human papillomavirus infection among 71,435 women in Jiangxi Province, China. J Infect Public Health. 2017;10:783–88. doi:10.1016/j.jiph.2017.01.011.
   PubMed Web of Science ®Google Scholar
• Zeng XX, Yan LX, Huang XX, He CH, Liu WG, Yuan WQ, Qiu Y-P, Liu Z-X. Prevalence and genotype distribution of human papillomavirus among Hakka women in China. Ann Transl Med. 2016;4:276. doi:10.21037/atm.
   PubMed Web of Science ®Google Scholar
• Luo ZY, Chen Q, Yang H, Lin M, Chen CY, Yang C, Yang L-Y. The prevalence and genotype of human papillomavirus from patients with genital warts in Eastern Guangdong province. Asian Pac J Cancer Prev. 2015;16:5675–79. doi:10.7314/APJCP.2015.16.14.5675.
   PubMedGoogle Scholar
• Gadelha SR, Soares-Barreto DMV, Costa GB, Leal VCN, Gomes LGS, Santos UR, Ferreira GCS, Carvalho LD, Soraes-Almeida SMV, Mello MAG, et al. Clinical, laboratory and epidemiological aspects of HPV infection in a low-income population from South Bahia, Brazil. Epidemiol Infect. 2017;145(16): 3398–404.
   PubMed Web of Science ®Google Scholar
• Volpini LPB, Boldrini NAT, de Freitas LB, Miranda AE, Spano LC. The high prevalence of HPV and HPV16 European variants in cervical and anal samples of HIV-seropositive women with normal Pap test results. PLoS One. 2017;12:e0176422. doi:10.1371/journal.pone.0176422.
   PubMed Web of Science ®Google Scholar
• Low HC, Silver MI, Brown BJ, Leng CY, Blas MM, Gravitt PE, Woo YL. Comparison of Hybribio GenoArray and Roche human papillomavirus (HPV) linear array for HPV genotyping in anal swab samples. J Clin Microbiol. 2015;53:550–56. doi:10.1128/JCM.02274-14.
   PubMed Web of Science ®Google Scholar
• Zhang L, Lin Y, Li JK. Concordance in cervical HPV detection between hybrid capture 2 and HPV GenoArray tests. Asian Pac J Cancer Prev. 2014;15:4465–66. doi:10.7314/APJCP.2014.15.11.4465.
   PubMedGoogle Scholar
• Zeng Z, Yang H, Li Z, He X, Griffith CC, Chen X, Guo X, Zheng B, Wu S, Zhao C, et al. Prevalence and genotype distribution of HPV infection in China: analysis of 51,345 HPV genotyping results from China’s largest CAP certified laboratory. J Cancer. 2016;7:1037–43. doi:10.7150/jca.14971.
   PubMed Web of Science ®Google Scholar
• Zhang C, Huang J, Wu Z, Mei X, Shi W. Prevalence and genotype distribution of human papillomavirus among females in the suburb of Shanghai, China. J Med Virol. 2018;90:157–64. doi:10.1002/jmv.24899.
   PubMed Web of Science ®Google Scholar
• Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, de Sanjosé S. ICO/IARC information centre on HPV and Cancer (HPV information centre). Human papillomavirus and related diseases in the world. Summary Report 22 January 2019. [Date Accessed]
   Google Scholar
• Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244–65. doi:10.1136/jcp.55.4.244.
   PubMed Web of Science ®Google Scholar
• Castellsague X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol. 2008;110:S4–7.
   PubMed Web of Science ®Google Scholar
• Dickson EL, Vogel RI, Geller MA, Downs LS Jr. Cervical cytology and multiple type HPV infection: a study of 8182 women ages 31–65. Gynecol Oncol. 2014;133:405–08. doi:10.1016/j.ygyno.2014.03.552.
   PubMed Web of Science ®Google Scholar
• Ayres ARG, Silva GAE, Teixeira MTB, Duque KCD, Machado M, Gamarra CJ, Levi JE. HPV in women assisted by the family health strategy. Rev Saude Publica. 2017;51:92.
   PubMed Web of Science ®Google Scholar
• Yetimalar H, Kasap B, Cukurova K, Yildiz A, Keklik A, Soylu F. Cofactors in human papillomavirus infection and cervical carcinogenesis. Arch Gynecol Obstet. 2012;285:805–10. doi:10.1007/s00404-011-2034-3.
   PubMed Web of Science ®Google Scholar
• Kapeu AS, Luostarinen T, Jellum E, Dillner J, Hakama M, Koskela P, Lenner P, Love A, Mahlamaki E, Thoresen S, et al. Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks. Am J Epidemiol. 2009;169:480–88. doi:10.1093/aje/kwn354.
   PubMed Web of Science ®Google Scholar
• Coker AL, Bond SM, Williams A, Gerasimova T, Pirisi L. Active and passive smoking, high-risk human papillomaviruses and cervical neoplasia. Cancer Detect Prev. 2002;26:121–28. doi:10.1016/S0361-090X(02)00039-9.
   PubMedGoogle Scholar
• Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202:1789–99. doi:10.1086/653024.
   PubMed Web of Science ®Google Scholar